Fred Alger Management’s Jade Biosciences JBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding JBIO
RCM
SI
TCM
AVLSA
DM
AG
BBA
Fred Alger Management's JBIO Position: Q2 2024 in Review
Fred Alger Management sold out of Jade Biosciences (JBIO) in Q2 2024, closing a stake of 1,251 shares — an estimated $1.29M sold.
Fred Alger Management first reported a position in JBIO in Q4 2021 and held it in 10 quarters. The position peaked at $4.34M in Q4 2022. 80 funds tracked by Wall St. Rank hold JBIO as of Q2 2024.
- Fred Alger Management reported no remaining Jade Biosciences position as of Q2 2024 after selling out during the quarter.
- Fred Alger Management sold 1,251 Jade Biosciences shares in Q2 2024, an estimated $1.29M.
- Fred Alger Management first reported a position in Jade Biosciences in Q4 2021 and held it in 10 quarters.
- Fred Alger Management's Jade Biosciences position peaked at $4.34M in Q4 2022.
- 80 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2024.
Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.